Immunic (IMUX) Non-cash Items (2014 - 2015)
Immunic's (IMUX) quarterly Non-cash Items came in at $3.0 million in Q2 2015, down 95.47% year-on-year from $65.5 million in Q2 2014, and little changed quarter-over-quarter from $3.0 million in Q1 2015.
Immunic (IMUX) Non-cash Items (2014 - 2015) Analysis & Trends
Immunic has disclosed Non-cash Items across 2 years of filings, most recently posting $3.0 million for Q2 2015.
- Non-cash Items for Q2 2015 came in at $3.0 million, down 95.47% year-over-year; the trailing twelve-month figure through Jun 2015 was $3.0 million (down 95.47% YoY), and the FY2014 annual result was $3.0 million, changed N/A from the prior year.
- Non-cash Items came in at $3.0 million for Q2 2015 at Immunic, roughly flat from $3.0 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $65.5 million in Q2 2014 to a low of $3.0 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2.96 Mn |
| Jun 30, 2015 | 2.96 Mn |
| Mar 31, 2015 | 2.96 Mn |
| Mar 31, 2015 | 2.96 Mn |
| Dec 31, 2014 | 2.98 Mn |
| Dec 31, 2014 | 2.98 Mn |
| Sep 30, 2014 | 3.13 Mn |
| Sep 30, 2014 | 3.13 Mn |
| Jun 30, 2014 | 65.48 Mn |
| Jun 30, 2014 | 65.48 Mn |
| Mar 31, 2014 | 15.03 Mn |
| Mar 31, 2014 | 15.03 Mn |